Medidata Study Experience

  1. Simulants: Medidata's Generative AI Algorithm For Generating Synthetic Clinical Data 8/29/2025

    By coupling domain expertise with generative AI, synthetic data is emerging as a critical enabler of safer, faster, and more inclusive clinical development.

  2. Intelligent Clinical Trials: Enhance Study Design And Live Forecasting 8/29/2025

    The integration of standardized, regulatory-grade clinical trial data has become central to advancing trial design and execution.

  3. Medidata CTMS - On Time. On Budget. In Sync 8/4/2025

    Learn how you can build support for both sponsor-led and CRO-managed trials with seamless execution, transparency, and control.

  4. Why Customers Are Switching To Medidata CTMS And eTMF 7/17/2025

    Discover a CTMS that leads the market with top rankings and offers unmatched integration, automation, and user experience for faster, more efficient clinical trial execution.

  5. A New Approach To Dynamic Clinical Oversight With Centralized Insights 7/10/2025

    RBQM is transforming clinical trial oversight. By automating protocol digitalization, site selection, and risk assessments 360° Monitoring enables the proactive identification of CtQ factors.

  6. Achieve Financial Management Success With Rave CTFM 6/17/2025

    Achieve operational and resource planning success for your clinical trial with the help of Rave Clinical Trial Financial Management (CTFM).

  7. Medidata CTMS Leads The Industry 5/16/2025

    The 2024 Everest Group PEAK Matrix assessment has named Medidata CTMS the leading Clinical Trial Management System (CTMS).

  8. Accelerate Your Operations With Smarter Trial Management 1/22/2025

    Learn about a cloud-based solution that centralizes clinical and operational data to improve the efficiency and oversight of clinical trials.

  9. Intelligent Trials: Design and Execute Faster Trials with AI-Powered Insights 11/19/2024

    Explore how Intelligent Trials leverages the industry’s largest clinical dataset to accelerate enrollment, improve diversity, and provide real-time insights, ensuring efficient, data-driven trial success.

  10. FDA Draft Guidance On Diversity Action Plan Requirements 10/24/2024

    Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.